Neopterin in inflammation and oxidative stress

Area of Science:

• Biochemistry
• Immunology
• Pathophysiology

Background:

• Chronic diseases like cardiovascular disease and dementia are linked to inflammation and oxidative stress.
• Current biomarkers (e.g., C-reactive protein) have limitations in specificity and capturing underlying mechanisms.
• Neopterin, a pteridine derivative, is emerging as a potential indicator of immune activation and oxidative stress.

Purpose of the Study:

• To review the interplay between inflammation, oxidative stress, and chronic diseases.
• To evaluate the limitations of existing biomarkers for inflammation and oxidative stress.
• To assess neopterin as a potential biomarker for dysregulated inflammation and redox balance.

Main Methods:

• Literature review of studies on inflammation, oxidative stress, and neopterin.
• Analysis of current biomarker limitations.
• Synthesis of evidence supporting neopterin's role.

Main Results:

• Inflammation and oxidative stress are key in atherosclerosis, cardiovascular disease, rheumatic diseases, and dementia.
• Existing biomarkers lack specificity and fail to reflect upstream molecular events.
• Neopterin demonstrates potential in reflecting cellular immune responses and redox imbalance.

Conclusions:

• Neopterin may offer a more comprehensive biomarker for inflammatory and oxidative stress-related conditions.
• Further research is needed to fully establish neopterin's clinical utility.
• Addressing biomarker limitations is crucial for managing chronic diseases effectively.